TrialBlood advances2025

Peripheral neuropathy in the phase 3 ASPEN study of Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia.

Benjamin M Heyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.